News Releases News Releases HOME HOME

August 10, 2000

Taisho Establishes Beijing Office

Taisho Pharmaceutical Co., Ltd. (President, Akira Uehara) announces a further step in its global strategy with the establishment of a representative office in Beijing, People's Republic of China. This office will serve as a base for vitamin drink marketing research in China.

With the population swelling over 1.2 billion, the market potential in China is immense. We feel that the recent economic success presents a lucrative opportunity, and are confident that the Chinese market can play a crucial role in our global strategy. Taisho already operates a subsidiary in Honk Kong, and Shanghai Taisho Guan Sheng Yuan Co., Ltd. handles sales in the eastern areas, including Shanghai. Sales activity in the south, Guangzhou, and the north, Tianjin and Beijing, transpire through agents. This enables comprehensive coverage of coastal China, where population and economic activity are concentrated.

Internationally, we operate with 13 affiliated companies for business development, and our offices (or branch offices) for business development overseas include: our London branch, an office in New Jersey (USA) and one in Milan, Italy. The Beijing office will be the fourth. Through these international business centers, we are focused on developing our vitamin drink business and continue to actively seek out alliances with biopharmaceuticals enterprises for new product development.

Taisho's Beijing Office
Address Room 212 Chang Fu Gong Center
26, Jian Guo Men Wai St.
Beijing, China 100022
Office Head Masatoshi Kawada